Skip to main content

AusPAR: Luspatercept

Australian Public Assessment Report
AusPAR
Device/Product Name
Reblozyl
Active ingredients
Luspatercept
AusPAR Date
Published
Sponsor
Submission Number
PM-2020-01706-1-6
Submission Type
New biological entity
Decision
Approved

Help us improve the Therapeutic Goods Administration site